Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1988-05-12
1990-01-16
Chan, Nicky
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514472, 514471, 514655, 549415, 549424, 549425, 549472, 549480, 549492, 564387, A61K 3135, A61K 3134, A61K 31135
Patent
active
048943924
ABSTRACT:
Disclosed are specific aminoalkyl naphthalenediol derivatives that enhance host resistance to infectious organisms. Such agents are administered prophylactically to individuals whose resistance to infection is comprised by chemotherapy, surgery, burns or other forms of severe stress.
REFERENCES:
patent: 3004069 (1961-10-01), Duffin
patent: 3009912 (1961-11-01), Duffin
British Journal of Pharm., vol. 12, pp. 171-175 (1957).
Synthetic Immunostimulants in Antitumor Therapy-Drugs of the Future, vol. 8, pp. 615-638 (1983).
Immunomodulators in the Immunotherapy of Cancer and Other Diseases-Trends in Pharmacological Sciences (TIPS), pp. 191-194 (1982).
The Experimental and Clinical Use of Immunomodulating Drugs in the Prophylaxis and Treatment of Infections-Infection, vol. 12, p. 1957 (1984).
Durette Philippe L.
Gallagher Timothy F.
Chan Nicky
Merck & Co. , Inc.
LandOfFree
Aminoalkyl naphthalenediols as host resistance enhancers does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Aminoalkyl naphthalenediols as host resistance enhancers, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Aminoalkyl naphthalenediols as host resistance enhancers will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1335097